Therasid Bioscience
Latest round
- Series A
Last raised
- Jun 2019
Total raised
- $5.1M
Investors
- 3
About Therasid Bioscience
Based in Gyeonggi-do, South Korea and founded in 2017, Therasid Bioscience operates as a biotechnology company that focuses on the development of drugs for the treatment of non-alcoholic steatohepatitis. The company'NASH platform is based on hepatocyte, Kupffer cell and hepatic stellate cell which are representative of liver cells. The company has the diverse NASH pipelines ranging from earyl stage to clinical stage. The pipelines include TB-840, TB-RB, TB-DK, TB-IH, which can provide an opportunity to develop the combination therapy for NASH.
Who invested in Therasid Bioscience
3 investors across 1 round
See all investors in Therasid Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 17, 2019
Amount
$5.1M
Investors
Questions about Therasid Bioscience
Who invested in Therasid Bioscience?
Therasid Bioscience has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Therasid Bioscience raised?
Therasid Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Therasid Bioscience last raise money?
Therasid Bioscience's most recent round on record is a Series A, in Jun 2019.
What does Therasid Bioscience do?
Based in Gyeonggi-do, South Korea and founded in 2017, Therasid Bioscience operates as a biotechnology company that focuses on the development of drugs for the treatment of non-alcoholic steatohepatitis.
Where is Therasid Bioscience headquartered?
Therasid Bioscience is headquartered in Gyeonggi-do, South Korea.
Which VCs invest in companies like Therasid Bioscience?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Therasid Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Therasid Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.